Sagimet Biosciences Inc. (SGMT)
Largest Insider Buys in Sector
SGMT Stock Price History Chart
SGMT Stock Performance
About Sagimet Biosciences Inc.
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences …
Insider Activity of Sagimet Biosciences Inc.
Over the last 12 months, insiders at Sagimet Biosciences Inc. have bought $63,731 and sold $178,175 worth of Sagimet Biosciences Inc. stock.
On average, over the past 5 years, insiders at Sagimet Biosciences Inc. have bought $271,865 and sold $94,383 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Happel David (President & CEO) — $63,731.
The last purchase of 12,100 shares for transaction amount of $63,731 was made by Happel David (President & CEO) on 2024‑03‑26.
List of Insider Buy and Sell Transactions, Sagimet Biosciences Inc.
| 2024-07-23 | Sale | Executive Chairman | 23,625 0.0429% | $3.17 | $74,830 | +25.54% | ||
| 2024-07-19 | Sale | General Counsel and CCO | 10,914 0.0194% | $3.10 | $33,830 | +30.42% | ||
| 2024-07-19 | Sale | Executive Chairman | 14,062 0.025% | $3.10 | $43,605 | +30.42% | ||
| 2024-07-19 | Sale | Chief Medical Officer | 8,357 0.0148% | $3.10 | $25,910 | +30.42% | ||
| 2024-03-26 | President & CEO | 12,100 0.0365% | $5.27 | $63,731 | -19.12% | |||
| 2023-07-18 | Sale | 10 percent owner | 662 0.0061% | $16.00 | $10,592 | -66.48% | ||
| 2023-07-18 | 10 percent owner | 30,000 0.275% | $16.00 | $480,000 | -66.48% |
Insider Historical Profitability
| Happel David | President & CEO | 639200 2.0838% | $4.95 | 1 | 0 | |
| NEW ENTERPRISE ASSOCIATES 13 LP | 10 percent owner | 3850275 12.5519% | $4.95 | 1 | 1 | <0.0001% |